PlainRecalls
FDA Drug Low Class III Terminated

Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487, Manufactured by: Pharmaceutics International Inc. Hunt Valley, MD 21031

Reported: November 21, 2018 Initiated: November 6, 2018 #D-0279-2019

Product Description

Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487, Manufactured by: Pharmaceutics International Inc. Hunt Valley, MD 21031

Reason for Recall

Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.

Details

Units Affected
9,193 bottles
Distribution
Nationwide within the United States
Location
Boca Raton, FL

Frequently Asked Questions

What product was recalled?
Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487, Manufactured by: Pharmaceutics International Inc. Hunt Valley, MD 21031. Recalled by Breckenridge Pharmaceutical, Inc.. Units affected: 9,193 bottles.
Why was this product recalled?
Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 21, 2018. Severity: Low. Recall number: D-0279-2019.